⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic
prnewswire.com
ABBV
AZN
BMY
LLY
NVO
Decades of Neglect Leaves Millions of People with COPD at Risk--National COPD Leaders Call for Urgent Policy Action USA - English USA - English USA - English
prnewswire.com
AZN
SNY
REGN
GSK
Global Radiopharmaceuticals Market Set for Significant Expansion at a CAGR of ~10% by 2034 with Increasing Adoption of Targeted Radiotherapy | DelveInsight
prnewswire.com
LH
TH
GEHC
EL
AZN
AMGN
PFE
MRK
BMY
REGN
GILD
ABBV
SNY
XRAY
BRKR
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
businesswire.com
AZN
Next Generation Drug Conjugates Market 2026-2035 - Expansion into Non-Oncology Therapeutic Areas Present Opportunities for the $15.75 Billion Market
globenewswire.com
AZN
PFE
NVS
ALNY
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
globenewswire.com
AMGN
CARG
REGN
MRK
AZN
GILD
BIIB
ALGT
AUTL
FIVE
Sensorion nomme Fred Chereau au poste de Directeur Général
businesswire.com
SENS
AZN
ENHERTU ® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
businesswire.com
AZN
Enhertu ® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
businesswire.com
AZN
ULTOMIRIS Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
globenewswire.com
AZN